IGF2: epigenetic regulation and role in development and disease.

[1]  D. Shima,et al.  Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability , 1995, FEBS letters.

[2]  A. Feinberg,et al.  An X Chromosome Gene, WTX, Is Commonly Inactivated in Wilms Tumor , 2007, Science.

[3]  R. Medema,et al.  The X Factor: Skewing X Inactivation towards Cancer , 2007, Cell.

[4]  S. Grimmond,et al.  Novel genes regulated by Sonic Hedgehog in pluripotent mesenchymal cells , 2002, Oncogene.

[5]  H.J. Kim,et al.  Regulation of vascular endothelial growth factor expression by insulin‐like growth factor‐II in human keratinocytes, differential involvement of mitogen‐activated protein kinases and feedback inhibition of protein kinase C , 2005, The British journal of dermatology.

[6]  F. Minuto,et al.  The IGF system and bone. , 2005, Journal of endocrinological investigation.

[7]  W. Daughaday,et al.  Letter to the Editor: On the Nomenclature of the Somatomedins and Insulin-Like Growth Factors , 1987 .

[8]  M. Nóbrega,et al.  Gene Expression Profiling Leads to Identification of GLI1-binding Elements in Target Genes and a Role for Multiple Downstream Pathways in GLI1-induced Cell Transformation* , 2002, The Journal of Biological Chemistry.

[9]  A. Feinberg,et al.  The epigenetic progenitor origin of human cancer , 2006, Nature Reviews Genetics.

[10]  Y. M. Lee,et al.  Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia. , 1999, Cancer research.

[11]  Takayuki Asahara,et al.  The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors , 2001, Nature Medicine.

[12]  H. Temin,et al.  Multiplication‐stimulating activity for chicken embryo fibroblasts from rat liver cell conditioned medium: A family of small polypeptides , 1973, Journal of cellular physiology.

[13]  G. Todaro,et al.  Purification and primary structure of a polypeptide with multiplication-stimulating activity from rat liver cell cultures. Homology with human insulin-like growth factor II. , 1981, The Journal of biological chemistry.

[14]  H. Dvorak.  Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  W. Daughaday,et al.  On the nomenclature of the somatomedins and insulin-like growth factors. , 1987, Molecular endocrinology.

[16]  P. Sánchez,et al.  Gli and hedgehog in cancer: tumours, embryos and stem cells , 2002, Nature Reviews Cancer.

[17]  Jeannie T. Lee,et al.  Tsix, a gene antisense to Xist at the X-inactivation centre , 1999, Nature Genetics.

[18]  A. R. I. Altaba.  Gli proteins encode context-dependent positive and negative functions: implications for development and disease , 1999 .

[19]  A. Feinberg,et al.  Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor. , 2001, Journal of the National Cancer Institute.

[20]  Victor V Lobanenkov,et al.  Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes. , 2005, Cancer research.

[21]  Peter Schmidtke,et al.  Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Lyon.  Gene Action in the X-chromosome of the Mouse (Mus musculus L.) , 1961, Nature.

[23]  M. Ladanyi,et al.  Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site. , 2003, Human molecular genetics.

[24]  E. Wagner,et al.  Regulation of embryonic growth and lysosomal targeting by the imprintedIgf2/Mpr gene , 1994, Nature.

[25]  R Ohlsson,et al.  CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. , 2001, Trends in genetics : TIG.

[26]  P. Jelinic,et al.  Loss of imprinting and cancer , 2007, The Journal of pathology.

[27]  J. Florini,et al.  Variation Among Cell Types in the Signaling Pathways by which IGF-I Stimulates Specific Cellular Responses* , 1999, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[28]  E. Froesch,et al.  ANTIBODY-SUPPRESSIBLE AND NONSUPPRESSIBLE INSULIN-LIKE ACTIVITIES IN HUMAN SERUM AND THEIR PHYSIOLOGIC SIGNIFICANCE. AN INSULIN ASSAY WITH ADIPOSE TISSUE OF INCREASED PRECISION AND SPECIFICITY. , 1963, The Journal of clinical investigation.

[29]  Yun‐Sil Lee,et al.  Insulin-like growth factor-II regulates the expression of vascular endothelial growth factor by the human keratinocyte cell line HaCaT. , 2004, The Journal of investigative dermatology.

[30]  C. Nüsslein-Volhard,et al.  Mutations affecting the cardiovascular system and other internal organs in zebrafish. , 1996, Development.

[31]  Andreas Zimmer,et al.  Patched Target Igf2 Is Indispensable for the Formation of Medulloblastoma and Rhabdomyosarcoma* , 2000, The Journal of Biological Chemistry.

[32]  S. Tilghman,et al.  Disruption of imprinting caused by deletion of the H19 gene region in mice , 1995, Nature.

[33]  D. Hill,et al.  Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II) , 1995, British Journal of Cancer.

[34]  D. Hanahan,et al.  A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis , 1994, Nature.

[35]  T. Wagner,et al.  A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[36]  C. Roberts,et al.  The insulin-like growth factor system and cancer. , 2003, Cancer letters.

[37]  T. Ekström,et al.  Overlapping patterns of IGF2 and H19 expression during human development: biallelic IGF2 expression correlates with a lack of H19 expression. , 1994, Development.

[38]  A. Feinberg,et al.  Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor risk. , 2005, Cancer research.

[39]  Yang Liu,et al.  FOXP3 Is an X-Linked Breast Cancer Suppressor Gene and an Important Repressor of the HER-2/ErbB2 Oncogene , 2008, Cell.

[40]  J. Harper,et al.  Insulin‐like growth factor ligands, receptors, and binding proteins in cancer , 2005, The Journal of pathology.

[41]  T. Ekström,et al.  Overlapping patterns of IGF 2 and H 19 expression during human development : biallelic IGF 2 expression correlates with a lack of H 19 expression , 2022 .

[42]  T. Moore,et al.  Multiple imprinted sense and antisense transcripts, differential methylation and tandem repeats in a putative imprinting control region upstream of mouse Igf2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[43]  R. Baxter,et al.  Cellular actions of the insulin-like growth factor binding proteins. , 2002, Endocrine reviews.

[44]  G. Semenza,et al.  Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. , 1999, Annual review of cell and developmental biology.

[45]  F. Peruzzi,et al.  The IGF‐1 receptor in cancer biology , 2003, International journal of cancer.

[46]  Jeannie T. Lee,et al.  Identification of a Ctcf cofactor, Yy1, for the X chromosome binary switch. , 2007, Molecular cell.

[47]  A. Efstratiadis,et al.  Parental imprinting of the mouse insulin-like growth factor II gene , 1991, Cell.

[48]  Michael Q. Zhang,et al.  Analysis of the Vertebrate Insulator Protein CTCF-Binding Sites in the Human Genome , 2007, Cell.

[49]  M. Dyer,et al.  Indian hedgehog activates hematopoiesis and vasculogenesis and can respecify prospective neurectodermal cell fate in the mouse embryo. , 2001, Development.

[50]  E. Wilson,et al.  Autocrine Growth Factor Signaling by Insulin-like Growth Factor-II Mediates MyoD-stimulated Myocyte Maturation* , 2003, Journal of Biological Chemistry.

[51]  W. Reik,et al.  Placental-specific IGF-II is a major modulator of placental and fetal growth , 2002, Nature.

[52]  W. Reik,et al.  How imprinting centres work , 2006, Cytogenetic and Genome Research.

[53]  Hui Ling Chen,et al.  CTCF Mediates Interchromosomal Colocalization Between Igf2/H19 and Wsb1/Nf1 , 2006, Science.

[54]  R. A. van der Kammen,et al.  The human insulin‐like growth factor II gene contains two development‐specific promoters , 1987, FEBS letters.

[55]  K. W. Kim,et al.  Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. , 1998, Cancer research.

[56]  Victor V Lobanenkov,et al.  Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells. , 2005, Cancer research.

[57]  M. Nakafuku,et al.  Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: implication of Gli2 and Gli3 as primary mediators of Shh signaling. , 1999, Development.

[58]  E. Rinderknecht,et al.  Amino-terminal sequences of two polypeptides from human serum with nonsuppressible insulin-like and cell-growth-promoting activities: evidence for structural homology with insulin B chain. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[59]  Robyn M. B. Loureiro,et al.  Transcriptional regulation of vascular endothelial growth factor in cancer. , 2005, Cytokine & growth factor reviews.

[60]  Alexis Carrel,et al.  ARTIFICIAL ACTIVATION OF THE GROWTH IN VITRO OF CONNECTIVE TISSUE , 1913, The Journal of experimental medicine.

[61]  E. Wilson,et al.  Control of MyoD Function during Initiation of Muscle Differentiation by an Autocrine Signaling Pathway Activated by Insulin-like Growth Factor-II* , 2006, Journal of Biological Chemistry.

[62]  G. Rao,et al.  Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice , 2004, Oncogene.

[63]  M. Bartolomei,et al.  Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and Igf2. , 1998, Genes & development.

[64]  W. Daughaday,et al.  Somatomedin: Proposed Designation for Sulphation Factor , 1972, Nature.

[65]  Pawel Stankiewicz,et al.  Genomic Disorders: Molecular Mechanisms for Rearrangements and Conveyed Phenotypes , 2005, PLoS genetics.

[66]  W. Reik,et al.  Igf2 imprinting in development and disease. , 2000, The International journal of developmental biology.

[67]  P. Ingham,et al.  Insights into early vasculogenesis revealed by expression of the ETS-domain transcription factor Fli-1 in wild-type and mutant zebrafish embryos , 2000, Mechanisms of Development.

[68]  Elizabeth J. Robertson,et al.  Role of insulin-like growth factors in embryonic and postnatal growth , 1993, Cell.

[69]  L. Powell-Braxton,et al.  IGF-I is required for normal embryonic growth in mice. , 1993, Genes & development.

[70]  M. Bartolomei,et al.  X-tra! X-tra! News from the mouse X chromosome. , 2006, Developmental biology.

[71]  Jeannie T. Lee,et al.  CTCF, a Candidate Trans-Acting Factor for X-Inactivation Choice , 2001, Science.

[72]  G. Booker,et al.  Molecular interactions of the IGF system. , 2005, Cytokine & growth factor reviews.

[73]  Maria Vernucci,et al.  Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome , 2004, Nature Genetics.

[74]  P. Rotwein,et al.  Evolution of insulin-like growth factor II: characterization of the mouse IGF-II gene and identification of two pseudo-exons. , 1990, DNA and Cell Biology.

[75]  B. Weinstein,et al.  sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. , 2002, Developmental cell.

[76]  Andrew P. McMahon,et al.  Sonic hedgehog Regulates Proliferation and Inhibits Differentiation of CNS Precursor Cells , 1999, The Journal of Neuroscience.

[77]  J. Wallace,et al.  The insulin receptor isoform exon 11- (IR-A) in cancer and other diseases: a review. , 2003, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[78]  D. Clemmons.  Insulin-like growth factor binding proteins and their role in controlling IGF actions. , 1997, Cytokine & growth factor reviews.

[79]  W. Reik,et al.  Transactivation of Igf2 in a mouse model of Beckwith–Wiedemann syndrome , 1997, Nature.

[80]  G. Semenza,et al.  Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. , 1999, Cancer research.

[81]  G. Felsenfeld,et al.  Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene , 2000, Nature.

[82]  A. Mackay,et al.  Heightened expression of CTCF in breast cancer cells is associated with resistance to apoptosis. , 2005, Cancer research.

[83]  M. White.  Regulating insulin signaling and beta-cell function through IRS proteins. , 2006, Canadian journal of physiology and pharmacology.

[84]  A. McMahon,et al.  Hedgehog is required for murine yolk sac angiogenesis. , 2002, Development.

[85]  C. Guidry,et al.  Changes in IGF activities in human diabetic vitreous. , 2004, Diabetes.

[86]  A. Reeve,et al.  Insulin-like growth factor 2 and overgrowth: molecular biology and clinical implications. , 1998, Molecular medicine today.

[87]  Yiling Lu,et al.  Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery , 2005, Nature Reviews Drug Discovery.

[88]  R. Rowntree,et al.  Identification of Developmentally Specific Enhancers for Tsix in the Regulation of X Chromosome Inactivation , 2005, Molecular and Cellular Biology.

[89]  A. Giatromanolaki,et al.  The vascular network of tumours — what is it not for? , 2003, The Journal of pathology.

[90]  A. McMahon,et al.  Sonic hedgehog regulates branching morphogenesis in the mammalian lung , 1998, Current Biology.

[91]  M. Surani,et al.  Expression and imprinting status of human PEG8/IGF2AS, a paternally expressed antisense transcript from the IGF2 locus, in Wilms' tumors. , 2000, Journal of biochemistry.

[92]  N. Miller,et al.  Biallelic expression of the IGF2 gene in human breast disease. , 1996, Human molecular genetics.

[93]  G. Booker,et al.  Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR. , 2004, Molecular endocrinology.

[94]  A. Filouš,et al.  [Retinopathy of prematurity]. , 1998, Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti.

[95]  Marcel Karperien,et al.  Structural and functional characteristics of the Val44Met insulin-like growth factor I missense mutation: correlation with effects on growth and development. , 2005, Molecular endocrinology.

[96]  C. Scott,et al.  The role of the M6P/IGF-II receptor in cancer: tumor suppression or garbage disposal? , 2004, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[97]  L. Stubbs,et al.  YY1 as a controlling factor for the Peg3 and Gnas imprinted domains. , 2007, Genomics.

[98]  M. White.  Regulating insulin signaling and β-cell function through IRS proteinsThis paper is one of a selection of papers published in this Special Issue, entitled Second Messengers and Phosphoproteins—12th International Conference. , 2006 .

[99]  A. Hoffman,et al.  Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor. , 2003, Cancer research.

[100]  Lois E. H. Smith,et al.  IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth , 2007, Proceedings of the National Academy of Sciences.

[101]  Jeannie T. Lee,et al.  Differential Methylation of Xite and CTCF Sites in Tsix Mirrors the Pattern of X-Inactivation Choice in Mice , 2006, Molecular and Cellular Biology.

[102]  W. Daughaday,et al.  A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. , 1957, The Journal of laboratory and clinical medicine.